Veru Inc (VERU)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $35.64M
Last updated: Nov 17, 2026 at 11:04 AM ET
Veru Inc (VERU) Stock Forecast
Analysts expect VERU to earn -$1.00 per share in the fiscal year ending Sep 30, 2027. Over the last 30 days, 1 estimate for the fiscal year ending Sep 30, 2027 was revised up and 0 down. For the quarter ending Dec 31, 2026, the EPS consensus is -$0.26.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
- Fiscal year ending Sep 30, 2027
- -$1.00
- EPS consensus
- Next report
- Dec 15, 2026
- Estimated
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Sep 30, 2027 | -$1.00 | -$1.17 to -$0.70 | 3 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.26 | -$0.33 to -$0.19 | 2 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Sep 30, 2027 | 1 | 0 |
| Quarter ending Dec 31, 2026 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Sep 30, 2027 has worsened from -$0.99.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Sep 30, 2027 | -$1.00 | -$1.00 | -$0.99 | -$0.99 | -$0.99 | N/A |
| Quarter ending Dec 31, 2026 | -$0.26 | -$0.19 | N/A | N/A | N/A | N/A |
Frequently Asked Questions About VERU
What is the VERU stock forecast?
Consensus analyst estimates put VERU's EPS at -$1.00 for the fiscal year ending Sep 30, 2027.
What EPS do analysts expect from VERU next year?
For the fiscal year ending Sep 30, 2027, the consensus EPS estimate is -$1.00, with estimates from -$1.17 to -$0.70 from 3 analysts.
How many analysts cover VERU?
3 analysts estimate EPS for VERU for the fiscal year ending Sep 30, 2027.
VERU pages: Overview, Earnings, Forecast, Financials, Competitors